Patents by Inventor Seung Hee JI

Seung Hee JI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240199679
    Abstract: The present invention relates to: an adenosine derivative capable of acting as an antagonist on A2A and A3 adenosine receptors through the introduction of substituents into the 2nd and 8th carbons and 6th and/or 9th amine(s); a pharmaceutical composition including the same; and a method for preparing the same, wherein the adenosine derivative regulates the activity of an A2A or A3 adenosine receptor, and thus can effectively prevent or treat brain diseases, cardiovascular diseases, sleep disorders, inflammation, immune system diseases and the like in which the receptors are involved.
    Type: Application
    Filed: March 24, 2022
    Publication date: June 20, 2024
    Applicants: FUTURE MEDICINE CO., LTD., HK INNO.N CORPORATION
    Inventors: Hyuk Woo LEE, Seo Hyun SON, Ji Yoon KANG, Hyu Jeong JANG, Sang Yeop AHN, Ji Won KIM, Joon Seok BYUN, Seung Hee JI, Seo Hyun KIM, Jong Ryoul CHOI
  • Patent number: 9890129
    Abstract: The present invention relates to a novel aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for preventing or treating constipation comprising the same as an active ingredient.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: February 13, 2018
    Assignee: CJ HEALTHCARE CORPORATION
    Inventors: Won-Hyuk Jung, Seung In Kim, Seung Hee Ji, Dong Hyun Ko, Seog Beom Song, Keun Ho Lee, Hyung Jin Jun, Dong Kyu Kim, Dong Hyun Kim
  • Patent number: 9815840
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: November 14, 2017
    Assignee: The Asan Foundation
    Inventors: Tae Gon Baik, Won-Hyuk Jung, Seung In Kim, Seung Chan Kim, Sook Kyung Park, Su Yeon Jung, Seung Hee Ji, So Young Ki, Min Cheol Kim, Eun Young Lee, Eun Mi Hong
  • Publication number: 20170283386
    Abstract: The present invention relates to a novel aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for preventing or treating constipation comprising the same as an active ingredient.
    Type: Application
    Filed: August 28, 2015
    Publication date: October 5, 2017
    Applicant: CJ Healthcare Corporation
    Inventors: Won-Hyuk Jung, Seung In Kim, Seung Hee Ji, Dong Hyun Ko, Seog Beom Song, Keun Ho Lee, Hyung Jin Jun, Dong Kyu Kim, Dong Hyun Kim
  • Publication number: 20160207931
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Application
    Filed: August 29, 2014
    Publication date: July 21, 2016
    Applicant: CJ Healthcare Corporation
    Inventors: Tae Gon BAIK, Won-Hyuk JUNG, Seung In KIM, Seung Chan KIM, Sook Kyung PARK, Su Yeon JUNG, Seung Hee JI, So Young KI, Min Cheol KIM, Eun Young LEE, Eun Mi HONG